What Well & Well Pharma does

Well & Well Pharma (Pvt) Ltd is a Pakistani pharmaceutical manufacturer operating a single cGMP- and WHO-compliant production facility in the National Industrial Zone, Islamabad (43,200 sq ft total area, 28,000 sq ft covered). The company manufactures generic medicines across five dosage formats — tablets, capsules, dry suspensions, sachets, and a dedicated Cephalosporin section producing injectable and oral antibiotic formulations — totaling approximately 127 active SKUs spanning anti-infectives, antivirals, cardiovascular agents, antihistamines, and pain management therapies. Independent Quality Control and Quality Assurance departments equipped with sophisticated analytical instruments enforce compliance with cGMP and WHO prerequisites, and the facility has twice received the 'Best Possible Grade' from the Pakistan Ministry of Health during inspections.

The company's commercial focus is institutional: a B2B/B2G sales motion targeting Pakistan's military and government healthcare apparatus, including the Pakistan Army, Pakistan Navy, Pakistan Airforce, Medical Directorate GHQ, and the Fauji Foundation. Products are sold on a per-unit pricing basis with publicly listed Maximum Retail Prices ranging from PKR 51 to PKR 13,566. A secondary, less-documented distribution channel serves civilian healthcare providers. The company is a privately held subsidiary of Well & Well Pharma UK Ltd, led by CEO Mr. Muzaffar Shah, and operates with an articulated R&D roadmap toward a center of excellence and academic collaborations. No revenue, headcount, or funding data is publicly disclosed.

Name

Well & Well Pharma

Legal name

Well & Well Pharma (Pvt) Ltd

Website

https://wellnwell.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Well & Well Pharma (Pvt) Ltd is a Pakistani cGMP- and WHO-compliant pharmaceutical manufacturer producing generic medicines and cephalosporin antibiotics, primarily supplying Pakistan's military and government healthcare institutions including the Pakistan Army, Navy, Airforce, and Fauji Foundation.

Ownership category

akta.pro rank

Headquarters

HQ city

Rawat

HQ country

Pakistan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from manufacturing and selling pharmaceutical products including tablets, capsules, dry suspensions, sachets, and cephalosporin antibiotics to healthcare providers and government institutions.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Well & Well Pharma (Pvt) Ltd manufactures generic pharmaceutical products at its cGMP-compliant facility in Islamabad, Pakistan, producing tablets, capsules, dry suspensions, sachets, and cephalosporin antibiotics (capsules, dry suspensions, and injectables). The company operates approximately 127 products across therapeutic categories including anti-infectives, antivirals, cardiovascular, and pain management, supplying Pakistan's military healthcare institutions and civilian healthcare providers.

Product overview

Well & Well Pharma is a pharmaceutical manufacturing company producing generic medicines under current Good Manufacturing Practices (cGMP). The company operates two primary product lines: General Products (tablets, capsules, dry suspensions, and sachets covering anti-infectives, cardiovascular, respiratory, and metabolic therapies) and Cephalosporin Products (a specialized line of cephalosporin-based antibiotics available in oral and injectable formulations). The portfolio includes approximately 98 general products and 29 cephalosporin products across various dosages and pack sizes. The company also maintains a separate category of temporarily held products due to market demand.

Differentiator

Problem solved

Functional benefit

Products and services

• General Pharmaceutical Products Approximately 98 generic pharmaceutical products in tablet, capsule, dry suspension, and sachet dosage forms covering antihistamines (e.g., Allerno/Levocetirizine), anti-infectives (e.g., Cipnolone/Ciprofloxacin, Clarivel/Clarithromycin, Zithrovel/Azithromycin), cardiovascular medications (e.g., Bisovel/Bisoprolol, Ramivel/Ramipril, Clopivel/Clopidogrel), antivirals, and pain management drugs. Supplied to Pakistan's military healthcare institutions and civilian healthcare providers.
• Cephalosporin Antibiotic Products Approximately 29 cephalosporin-based antibiotic products including capsules (e.g., Cefivel/Cefixime, Cephzin/Cephalexin, Welcor/Cefaclor, Weldro/Cefadroxil, Cephravel/Cephradine), dry suspensions, and injectable formulations (e.g., Taxonec/Cefotaxime, Cefravel/Cefoperazone, Classica/Ceftriaxone, Cefravel Plus/Cefoperazone+Sulbactam). Manufactured in a dedicated Cephalosporin section of the Islamabad facility.
• Quality Control and Quality Assurance Services Independent Quality Control and Quality Assurance function operating with sophisticated analytical instruments to ensure compliance with cGMP and WHO pre-requisites across all manufactured pharmaceutical products. Functions as the custodian of product quality and company repute.

Quantifiable outcome

• Twice awarded 'Best Possible Grade' by Ministry of Health

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Well & Well Pharma UK LtdcoreOthersWell & Well Pharma (Pvt) Ltd is a subsidiary company of Well & Well Pharma UK Ltd. The Pakistani subsidiary operates as the manufacturing and distribution arm, producing pharmaceutical products compliant with cGMP and WHO standards at its Islamabad facility.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Hilton Pharma: Pakistani pharmaceutical manufacturer producing branded generics and specialty formulations across antibiotics, cardiovascular, and chronic disease categories. Comparable scale and B2B institutional sales model to Well & Well Pharma.
• Getz Pharma: One of Pakistan's largest pharmaceutical manufacturers producing generic and branded formulations across multiple therapeutic categories including antibiotics. Operates cGMP/WHO-compliant manufacturing facilities and supplies institutional buyers, directly comparable to Well & Well Pharma's profile.
• Ferozsons Laboratories: Pakistani pharmaceutical manufacturer with strong institutional and government customer relationships. Produces antibiotics and other essential medicines under cGMP standards, similar to Well & Well Pharma's institutional customer base and product mix.
• AGP Limited: One of the largest Pakistani pharmaceutical manufacturers with diverse product portfolio across multiple therapeutic areas. Operates certified manufacturing facilities and serves institutional customers, directly comparable to Well & Well Pharma's profile.
• Searle Pakistan: Major Pakistani pharmaceutical manufacturer with a broad portfolio of generics spanning antibiotics, cardiovascular, and metabolic therapies. Operates certified manufacturing facilities with both domestic and export distribution, comparable in scale and product mix to Well & Well Pharma.
• Sami Pharmaceuticals: Pakistani pharmaceutical manufacturer producing generic formulations including antibiotics and other essential medicines. Similar scale and institutional customer focus as Well & Well Pharma.

Broad incumbents

• Abbott Pakistan: Multinational pharmaceutical company with Pakistan manufacturing and distribution. Overlaps with Well & Well Pharma's therapeutic categories but operates at much larger scale and broader portfolio.
• Sanofi Pakistan: Multinational pharmaceutical company with established Pakistan manufacturing operations. Overlaps with Well & Well Pharma in antibiotics and chronic disease categories, though at significantly larger scale and broader geographic reach.
• GSK Pakistan: Multinational pharmaceutical company with Pakistan presence. Overlaps in certain therapeutic categories including antibiotics, but at significantly larger scale and broader geographic reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Well & Well Pharma